Clinical Trials Browser

OTHER × Prostatic Neoplasms × Topotecan × Clear all

NCT00084565 2013-07-10

Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms